---
input_text: Nationwide retrospective study of critically ill adults with sickle cell
  disease in France. Little is known about patients with sickle cell disease (SCD)
  who require intensive care unit (ICU) admission. The goals of this study were to
  assess outcomes in patients admitted to the ICU for acute complications of SCD and
  to identify factors associated with adverse outcomes. This multicenter retrospective
  study included consecutive adults with SCD admitted to one of 17 participating ICUs.
  An adverse outcome was defined as death or a need for life-sustaining therapies
  (non-invasive or invasive ventilation, vasoactive drugs, renal replacement therapy,
  and/or extracorporeal membrane oxygenation). Factors associated with adverse outcomes
  were identified by mixed multivariable logistic regression. We included 488 patients
  admitted in 2015-2017. The main reasons for ICU admission were acute chest syndrome
  (47.5%) and severely painful vaso-occlusive event (21.3%). Sixteen (3.3%) patients
  died in the ICU, mainly of multi-organ failure following a painful vaso-occlusive
  event or sepsis. An adverse outcome occurred in 81 (16.6%; 95% confidence interval
  [95% CI], 13.3%-19.9%) patients. Independent factors associated with adverse outcomes
  were low mean arterial blood pressure (adjusted odds ratio [aOR], 0.98; 95% CI 0.95-0.99;
  p = 0.027), faster respiratory rate (aOR, 1.09; 95% CI 1.05-1.14; p < 0.0001), higher
  haemoglobin level (aOR, 1.22; 95% CI 1.01-1.48; p = 0.038), impaired creatinine
  clearance at ICU admission (aOR, 0.98; 95% CI 0.97-0.98; p < 0.0001), and red blood
  cell exchange before ICU admission (aOR, 5.16; 95% CI 1.16-22.94; p = 0.031). Patients
  with SCD have a substantial risk of adverse outcomes if they require ICU admission.
  Early ICU admission should be encouraged in patients who develop abnormal physiological
  parameters.
raw_completion_output: |-
  primary_disease: Sickle cell disease (SCD)

  medical_actions: Intensive care unit (ICU) admission; Life-sustaining therapies; Non-invasive ventilation; Invasive ventilation; Vasoactive drugs; Renal replacement therapy; Extracorporeal membrane oxygenation; Red blood cell exchange

  symptoms: Death; Multi-organ failure following a painful vaso-occlusive event; Sepsis; Low mean arterial blood pressure; Faster respiratory rate; High haemoglobin level; Impaired creatinine clearance

  chemicals: 

  action_annotation_relationships: ICU admission (for acute complications) TREATS acute chest syndrome IN Sickle cell disease (SCD); ICU admission (for acute complications) TREATS painful vaso-occlusive event IN Sickle cell disease (SCD); Non-invasive ventilation TREATS respiratory distress IN Sickle cell disease (SCD); Invasive ventilation TREATS respiratory distress IN Sickle cell disease (SCD); Vasoactive drugs TREATS low mean arterial blood pressure IN Sickle cell disease (SCD); Renal replacement therapy TREATS impaired creatinine clearance IN Sickle cell disease (SCD); Extracorporeal membrane oxygenation TREATS multi-organ failure IN Sickle cell disease (SCD); Red blood cell exchange TREATS high haemoglobin level IN Sickle cell disease (SCD)
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Red blood cell exchange TREATS high haemoglobin level IN Sickle cell disease (SCD)

  ===

extracted_object:
  primary_disease: MONDO:0007374
  medical_actions:
    - Intensive care unit (ICU) admission
    - Life-sustaining therapies
    - MAXO:0000506
    - MAXO:0000586
    - Vasoactive drugs
    - MAXO:0000600
    - MAXO:0000515
    - Red blood cell exchange
  symptoms:
    - Death
    - Multi-organ failure following a painful vaso-occlusive event
    - HP:0100806
    - Low mean arterial blood pressure
    - Faster respiratory rate
    - High haemoglobin level
    - Impaired creatinine clearance
  action_annotation_relationships:
    - subject: ICU admission
      predicate: TREATS
      object: acute chest syndrome
      qualifier: MONDO:0007374
      subject_qualifier: for acute complications
    - subject: ICU admission
      predicate: TREATS
      object: painful vaso-occlusive event
      qualifier: MONDO:0007374
      subject_qualifier: for acute complications
    - subject: <Non-invasive ventilation>
      predicate: <TREATS>
      object: <respiratory distress>
      qualifier: <Sickle cell disease>
      subject_extension: <Non-invasive ventilation>
    - subject: MAXO:0000586
      predicate: TREATS
      object: HP:0002098
      qualifier: MONDO:0007374
    - subject: Vasoactive drugs
      predicate: TREATS
      object: low mean arterial blood pressure
      qualifier: MONDO:0007374
      subject_extension: vasoactive drugs
    - subject: <Renal replacement therapy>
      predicate: <TREATS>
      object: <impaired creatinine clearance>
      qualifier: MONDO:0007374
      subject_extension: <Renal replacement therapy>
    - subject: MAXO:0000515
      predicate: TREATS
      object: multi-organ failure
      qualifier: MONDO:0007374
    - subject: Red blood cell exchange
      predicate: TREATS
      object: high haemoglobin level
      qualifier: MONDO:0007374
      subject_extension: Red blood cell exchange
named_entities:
  - id: MONDO:0011382
    label: sickle cell disease
  - id: MAXO:0010203
    label: echocardiography
  - id: MONDO:0007374
    label: Sickle Cell Disease (SCD)
  - id: HP:0001394
    label: Cirrhosis
  - id: HP:0002204
    label: Pulmonary embolus
  - id: HP:0001297
    label: Stroke
  - id: MONDO:0044348
    label: hemoglobinopathies
  - id: MONDO:0019740
    label: acquired thrombotic thrombocytopenic purpura (aTTP)
  - id: CHEBI:24261
    label: glucocorticoids
  - id: CHEBI:44423
    label: Hydroxyurea
  - id: CHEBI:35480
    label: Analgesics
  - id: CHEBI:33281
    label: Antibiotics
  - id: CHEBI:35705
    label: immunosuppressive agents
  - id: MONDO:0002049
    label: Thrombocytopenia
  - id: CHEBI:46195
    label: Acetaminophen
  - id: CHEBI:47381
    label: Diclofenac
  - id: HP:0007018
    label: Attention deficits
  - id: CHEBI:6443
    label: levonorgestrel
  - id: HP:0001518
    label: Small for gestational age
  - id: HP:0001622
    label: Preterm
  - id: HP:0011105
    label: Fluid overload
  - id: HP:0001944
    label: dehydration
  - id: HP:0006775
    label: Multiple Myeloma
  - id: MAXO:0000756
    label: Blood transfusions
  - id: HP:0001903
    label: Anaemia
  - id: HP:0004421
    label: Elevated systolic blood pressures
  - id: CHEBI:33699
    label: mRNA
  - id: MAXO:0000068
    label: Transplantation
  - id: MAXO:0000149
    label: Evaluation for an allogeneic hematopoietic stem cell transplant (HCT)
  - id: CHEBI:50443
    label: normal hematopoietic stem cells (HSCs)
  - id: MAXO:0001001
    label: Gene therapies
  - id: MONDO:0013517
    label: beta-thalassemia
  - id: MONDO:0005920
    label: Plasmodium falciparum malaria
  - id: HP:0001974
    label: Leukocytosis
  - id: HP:0001919
    label: Acute kidney injury
  - id: HP:0002140
    label: Ischemic stroke
  - id: HP:0002092
    label: Pulmonary hypertension
  - id: CHEBI:30413
    label: Heme
  - id: CHEBI:35143
    label: Hemoglobin
  - id: MONDO:0006079
    label: Acute Chest Syndrome (ACS)
  - id: MAXO:0000955
    label: noninvasive, bi-level positive airway pressure ventilation (BiPAP)
  - id: HP:0012418
    label: hypoxemia
  - id: MONDO:0005632
    label: Acute Chest Syndrome
  - id: HP:0001649
    label: elevated heart rate
  - id: HP:0012531
    label: pain
  - id: HP:0012532
    label: Chronic pain
  - id: CHEBI:125354
    label: Plerixafor
  - id: HP:0025085
    label: bloody stools
  - id: HP:0002027
    label: abdominal pain
  - id: MONDO:0100096
    label: covid-19
  - id: MAXO:0001017
    label: vaccination
  - id: MAXO:0000014
    label: radiotherapy
  - id: HP:0040319
    label: Dark urine
  - id: MONDO:0005136
    label: Malaria
  - id: MAXO:0001479
    label: Allogeneic hematopoietic stem cell transplantation
  - id: MAXO:0000950
    label: Supportive care
  - id: CHEBI:4027
    label: Cyclophosphamide
  - id: CHEBI:51451
    label: endothelin receptor antagonists
  - id: MONDO:0020380
    label: sickle cell anemia (SCA)
  - id: CHEBI:49005
    label: deferasirox
  - id: MONDO:0005290
    label: Rhabdomyolysis
  - id: CHEBI:9168
    label: Sirolimus
  - id: CHEBI:3770
    label: Trimethoprim/Sulfamethoxazole (TMP-SMX)
  - id: CHEBI:2453
    label: Acyclovir
  - id: HP:0040049
    label: macular oedema
  - id: CHEBI:18050
    label: l-glutamine
  - id: HP:0007760
    label: Sickle Cell Disease (SCD)
  - id: MAXO:0000503
    label: mechanical ventilation
  - id: MONDO:0018874
    label: Acute Myeloid Leukemia
  - id: CHEBI:17334
    label: Penicillin
  - id: MONDO:0003847
    label: Genetic Disorders
  - id: MAXO:0000573
    label: Assisted Reproductive Technology (ART)
  - id: HP:0000789
    label: infertility
  - id: MAXO:0000747
    label: Hematopoietic stem cell transplantation (HSCT)
  - id: MONDO:0019050
    label: hereditary hemoglobinopathies
  - id: MAXO:0000571
    label: Chronic transfusion (CT)
  - id: HP:0100699
    label: Scarring
  - id: HP:0002625
    label: Deep venous thrombosis (DVT)
  - id: MAXO:0001298
    label: therapy
  - id: CHEBI:6716
    label: depot medroxyprogesterone (DMPA)
  - id: CHEBI:59826
    label: progestin
  - id: MAXO:0000004
    label: Surgical intervention
  - id: HP:0200023
    label: Priapism
  - id: MAXO:0000011
    label: post-transplant (PT) cyclophosphamide
  - id: MAXO:0009065
    label: Intravenous push (IVP) analgesia
  - id: CHEBI:17303
    label: Morphine
  - id: MAXO:0000079
    label: Genetic counseling
  - id: MONDO:0009061
    label: Cystic fibrosis
  - id: MAXO:0010030
    label: Bone marrow transplantation
  - id: MAXO:0000506
    label: Non-invasive ventilation
  - id: MAXO:0000586
    label: Invasive ventilation
  - id: MAXO:0000600
    label: Renal replacement therapy
  - id: MAXO:0000515
    label: Extracorporeal membrane oxygenation
  - id: HP:0100806
    label: Sepsis
  - id: HP:0002098
    label: respiratory distress
